CGDAA Administration & Advisory Board

Felicia Brigitta Morton, Executive Director

Felicia has been an advocate for patients and families with CGD as well as X-linked CGD recessive carriers since 2013. She has worked with the Immune Deficiency Foundation and serves as a patient liaison for the Primary Immune Deficiency Treatment Consortium.

CGDAA Executive Board

Felicia B. Morton

Melissa L. Fernandez

Barbara D. Morton

Patient Advisory Board

Robert Karp, patient with CGD

Scott Vogel, former CGD patient after successful transplant

Carla Dean, autosomal patient with CGD

CGD Association of America Medical Advisory Board

Harry Malech, MD, National Institutes of Health

Chief, Genetic Immunotherapy Section

Deputy Chief, Laboratory of Clinical Immunology and Microbiology

National Institute of Allergy and Infectious Diseases, National Institutes of Health

Kathleen Sullivan, MD, PhD, Chief of the Division of Allergy and Immunology, Children's Hospital of Philadelphia

Jennifer Leiding, MD, Adjunct Associate Professor John's Hopkins University and Attending Physician, Orlando Health Arnold Palmer Hospital for Children

Peter Newburger, MD, Attending Physician, Dana-Farber/Boston Children's Cancer and Blood Disorders Center

Rebecca Marsh, MD, Clinical Director, Primary Immune Deficiency Program and Co-Director, Diagnostic Immunology Laboratories, Cincinnati Children's Hospital

Mary Dinauer, MD, PhD
Fred M. Saigh Distinguished Chair of Pediatric Research
Professor of Pediatrics , Washington University School of Medicine
St. Louis Children’s Hospital